Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  by Oh, Jong Hoon et al.
HORMONES - CYTOKINES - SIGNALING
Sequential effects of high glucose on mesangial cell transforming
growth factor-b1 and fibronectin synthesis
JONG HOON OH, HUNJOO HA, MI RA YU, and HI BAHL LEE
Hyonam Kidney Laboratory, Soon Chun Hyang University and Department of Pharmacology, Yonsei University College of Medicine,
Seoul, Korea
Sequential effects of high glucose on mesangial cell transforming
growth factor-b1 and fibronectin synthesis.
Background. Transforming growth factor (TGF)-b is recognized
as the final common mediator of the principal lesions of diabetic
nephropathy such as renal hypertrophy and mesangial expansion.
To gain better understanding of the temporal relationships be-
tween high glucose (HG) and mesangial cell (MC) TGF-b1
synthesis and between TGF-b1 and extracellular matrix (ECM)
synthesis, the present study examined early and sequential effects
of HG on TGF-b1 and fibronectin (FN) mRNA expression and
protein synthesis.
Methods. Confluent primary rat MC was stimulated with 5.6
(control) or 30 (high) mM glucose after synchronizing the growth
by incubation with serum-free media for 48 hours.
Results. Mesangial cell TGF-b1 mRNA expression increased
significantly in six hours and continued to increase until 48 hours
in response to HG. The level of TGF-b1 mRNA was 1.5-fold
higher than that of control glucose at six hours and 1.8-fold at 48
hours. TGF-b activity in heat-activated conditioned media under
HG increased 1.5- and 1.6-fold at 24 and 48 hours, respectively,
compared to control glucose. FN mRNA increased significantly at
24 and 48 hours and 1.4-fold that of control glucose at both time
points. FN protein also increased 1.5-fold that of control glucose
at 48 hours. Anti-TGF-b antibody completely abolished HG-
induced FN synthesis.
Conclusions. The present findings demonstrate that HG stimu-
lates TGF-b1 very early and prior to FN production and that
HG-induced FN production is mediated by TGF-b. This finding is
consistent with the view that TGF-b mediates increased ECM
accumulation by MC under high glucose conditions.
Excessive deposition of extracellular matrix (ECM) and
subsequent mesangial expansion is the principal structural
lesion of diabetic kidney [1, 2]. Transforming growth factor
(TGF)-b stimulates the deposition of ECM through (i)
directly up-regulating the genes of matrix proteins leading
to their increased synthesis, (ii) suppressing the production
of proteases that normally degrade the matrix and increas-
ing synthesis of the inhibitors of the same proteases, (iii)
modulating the expression of integrins on the cell’s surface
in a manner that facilitates attachment to the newly syn-
thesized matrix, and (iv) autoinducing its own production,
which greatly amplifies its action [3–6]. Increased expres-
sion of TGF-b and ECM mRNAs and proteins in the
kidneys of diabetic animals [7–15] and diabetic patients [9,
16, 17] implicates TGF-b in the pathogenesis of diabetic
nephropathy.
Mesangial cells cultured under high glucose exhibit in-
creased expression of ECM mRNAs and proteins [18, 19]
and is an accepted in vitro model of diabetic nephropathy.
Expression of TGF-b mRNA and bioactivity are also
increased in this in vitro model [20–22].
Recent studies have demonstrated that neutralizing an-
tibody against TGF-b significantly reduced high glucose-
induced collagen production in mesangial cells [21] and
fibronectin production in glomerular epithelial cells [23].
TGF-b1 antisense oligonucleotides [24] attenuated porcine
mesangial fibronectin and heparan sulfate proteoglycan
production stimulated by high glucose. Anti-TGF-b anti-
body also attenuated renal hypertrophy and ECM gene
expression in diabetic mice [25]. All these studies suggest
that TGF-b is the final common mediator of the principal
lesions of diabetic nephropathy [6].
Consistent with this hypothesis, increased TGF-b expres-
sion was observed in renal cortex very early after the onset
of diabetes and before manifestation of ECM expansion.
Streptozotocin-induced diabetic rats showed an increased
TGF-b expression at 24 hours after the induction of
diabetes as measured by polymerase chain reaction (PCR)
analysis [11]. A recent study utilizing in situ hybridization
demonstrated increased glomerular TGF-b1 mRNA ex-
pression at three days after injection of streptozotocin [15].
Spontaneous diabetic BB rat and NOD mouse [12] and
streptozotocin-induced diabetic mice [25] also exhibited
increased TGF-b1 mRNA and protein levels in the renal
cortex a few days after the appearance of glycosuria.
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However, the temporal relations between high glucose
and mesangial cell TGF-b1 mRNA expression and protein
synthesis and between TGF-b1 and fibronectin mRNA
expression and protein synthesis have not been established.
The present study examined early and sequential effects of
high glucose concentration on mesangial cell TGF-b1 and
fibronectin mRNA expression and protein synthesis. In
addition, the effect of neutralizing antibody to TGF-b on
fibronectin synthesis was determined to examine the role of




Mesangial cells were obtained by culturing glomeruli
isolated from kidneys of 100 to 150 g male Sprague-Dawley
rats by conventional sieving methods as previously de-
scribed [26, 27]. Mesangial cells were identified by phase
contrast microscopy according to the morphological crite-
ria and by immunofluorescence technique. Cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 20% fetal bovine serum (FBS), 100 U/ml peni-
cillin, 100 mg/ml streptomycin, 0.5 mg/ml fungizone, 44 mM
NaHCO3, and 14 mM N-2-hydroxy-ethylpiperazine-N9-2-
ethane sulfonic acid (HEPES). Near confluent mesangial
cells grown in 100 mm culture dish were incubated with
serum-free media for 48 hours to arrest and synchronize
the cell growth. After this time period, the media were
changed to fresh serum-free DMEM containing 5.6 or 30
mM glucose for 3 to 48 hours. Cells were also incubated
with 5.6 and 30 mM glucose media in the presence of 25
mg/ml neutralizing mouse anti-bovine TGF-b antibody (Ig
G fraction, neutralizes TGF-b1, -b2, and -b3; Genzyme
Corporation, Cambridge, MA, USA). After additional in-
cubation, the media were collected, centrifuged to remove
cell debris, and used for bioassay of TGF-b1 and immuno-
blot analysis of fibronectin. After removing the media, the
mesangial cells were washed with phosphate buffered sa-
line (PBS), then lysed using 1 ml of a mixture consisting of
4 M guanidium thiocyanate, 25 mM sodium citrate pH 7.0,
0.5% sarcosyl, and 0.1 M 2-mercaptoethanol for RNA
isolation. All experiments were performed using cells be-
tween the 6th and 8th passages.
Northern blot analysis
Standard Northern blot was performed as previously
described [28] after isolation of total RNA using the
method of Chomczynski and Sacchi [29]. In brief, cells were
homogenized with 4 M guanidium thiocyanate. Total pro-
tein and DNA were extracted with acid phenol, and RNA
precipitated with isopropanol. After washing with ethanol,
the amount of RNA was quantitated by measuring the
absorbance at 260 nm using a spectrophotometer (Ultra-
spec 3000; Pharmacia Biothech, England, UK). Twenty
micrograms of total RNA were electrophoresed through a
1.2% agarose gel with 2.2 M formaldehyde. The RNA from
the gel was transferred onto nylon membranes using a
capillary transfer and covalently cross-linked to the mem-
brane with UV light using a gene-linker (Bio-Rad, Rich-
mond, CA, USA).
Prehybridization was performed for five hours at 42°C
using a commercial prehybridization buffer (GIBCO BRL,
Gaitherburg, MD, USA). Hybridization was conducted for
20 hours at 42°C using excised cDNA inserts as probes after
[32P]dCTP-labeling by a random primer extension method
(Pharmacia Biotech, Uppsala, Sweden). Rat cDNA probes
for TGF-b1 and fibronectin were purchased from the
American Type Culture Collection (ATCC, Rockville, MD,
USA). Human glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) cDNA was constructed based on the previously
published sequence using the PCR [30]. The membranes
were washed three times for 30 minutes: first in 23 sodium
chloride and sodium citrate (SSC; 1 3 SSC is 0.15 M NaCl
and 0.015 M sodium citrate, pH 7.0) with 0.1% sodium
dodecyl sulfate (SDS) at room temperature; the second in
0.2 3 SSC with 0.1% SDS at room temperature; and the
third in 0.2 3 SSC with 0.1% SDS at 55°C. Autoradiogra-
phy was performed by exposing the blots to Kodak X-Omat
K XK-1 X-ray film with intensifying screens at 270°C for
one to five days. The blots were then rehybridized with a
32P-labeled human GAPDH cDNA probe as an internal
control to assess RNA quantity and integrity. Quantitation
of mRNA signals was performed by densitometry using
MCID (Imaging Research Inc., St. Catharines, Ontario,
Canada) and normalized with GAPDH mRNA signals.
Bioassay for TGF-b activity
The activity of TGF-b present in the conditioned media
was measured using the mink lung epithelial cell (MLEC)
growth inhibition assay, where human recombinant
TGF-b1 (Genzyme; 0.64 to 10,000 pg/ml) was used to
generate a standard curve [31]. Preliminary study revealed
undetectable TGF-b activity in the conditioned media
under our experimental condition. The activation of latent
TGF-b was performed by heating conditioned media at
80°C for 15 minutes. In brief, CCL-64 cells (ATCC) were
grown in 96-well culture plates with RPMI containing 5%
FBS and conditioned media for 96 hours. MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Thia-
zolyl blue) was then added and cells were incubated for
another eight hours. Elution buffer was added and cells were
incubated for additional 48 hours and optical density was
measured at 562 nm. Under our experimental condition,
half-maximally effective concentrations of TGF-b1 inhibiting
MLEC growth (EC50) was around 200 ng/liter. Uncondi-
tioned media containing 30 mM glucose did not exhibit
discernible effect on MLEC growth inhibition assay.
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Immunoblot analysis of fibronectin protein
Immunoblot analysis was performed to determine the
production and secretion of fibronectin into the mesangial
cell conditioned media [32]. After measuring the concen-
trations of protein by the Bradford method [33] using the
Bio-Rad assay, aliquots of conditioned media were mixed
with sample buffer containing SDS and b-mercaptoethanol
and heated at 95°C for 15 minutes. Samples were applied to
5% polyacrylamide gel and electrophoresed. A prestained
SDS-PAGE standard (broad range, Bio-Rad) was also
electrophoresed as a molecular weight marker. After elec-
trophoresis, the proteins were transferred onto a nitrocel-
lulose membrane using a transblot chamber with Tris
buffer. Western blots were incubated with rabbit anti-
mouse fibronectin (GIBCO BRL) for two hours at room
temperature. The membranes were washed with PBS-
Tween-20 for one hour and incubated with peroxidase-
conjugated secondary antibody, rabbit anti-IgG (Sigma
Chemical Company, St. Louis, MO, USA) for two hours at
room temperature. After washing, the membranes were
incubated with a color reagent (50 mg 3,39-diaminobenzi-
dine, 0.1 ml H2O2 in 100 ml PBS) for 15 minutes or ECL
detection reagents (Amersham Life Science, Little Chal-
font, England, UK) for precisely one minute followed by
autoradiography. Positive immunoreactive bands were
quantitated densitometrically and compared to controls.
Analysis of data
All results are expressed as mean 6 standard error (SE).
Analysis of variance was used to assess the differences
between multiple groups. If the F statistic was significant,
the mean values obtained from each group were then
compared by Fisher’s least significant difference method. A
P value , 0.05 was used as the criterion for a statistically
significant difference.
RESULTS
Time sequence of high glucose-induced TGF-b1 and
fibronectin mRNAs in mesangial cells
Quiescent mesangial cells grown in serum-free media for
two days expressed both TGF-b1 and fibronectin mRNAs
(Fig. 1). The steady state levels of TGF-b1 and GAPDH
mRNAs remained constant for an additional 48 hours
incubation in serum-free control glucose media. Fibronec-
tin mRNA expression tended to decrease, although the
difference between 0 and 48 hours did not reach statistical
significance (P . 0.05). The mRNA level in response to
high glucose was compared with that in response to control
glucose at a given time. As summarized in Table 1, the time
sequence of high glucose-induced TGF-b1 mRNA was
different from that of fibronectin. Mesangial cell TGF-b1
mRNA expression increased significantly at six hours (P ,
0.05) and continued to increase until up to 48 hours in
response to high glucose. The level of TGF-b1 mRNA was
1.53 that of control glucose at six hours and 1.83 at 48
hours. Compared to TGF-b1, the increase in fibronectin
mRNA expression in response to high glucose was some-
what delayed, significant only at 24 and 48 hours and 1.43
that of control glucose at both time points.
Effects of high glucose on mesangial cell TGF-b
bioactivity
MLEC growth inhibition assay of mesangial cell condi-
tioned media was performed to determine the translation
of TGF-b1 mRNA into protein synthesis and secretion.
Heat-activated conditioned media showed a time-depen-
dent increase in TGF-b1 activity in both control and high
glucose (P , 0.05; Fig. 2) in the face of little change in total
protein concentration (Table 2). High glucose significantly
Fig. 1. Representative Northern blot analysis
of mesangial cell expression of TGF-b1 and
fibronectin mRNAs. After incubation of
quiescent mesangial cells with control (C; 5.6
mM) or high (H; 30 mM) glucose for the given
period, total RNA was isolated, electrophoresed
and transferred onto nylon membranes.
Northern blots were hybridized with [32P]-
labeled cDNA probe for TGF-b1, fibronectin,
and GAPDH. Autoradiographs were developed
by exposing blots to X-ray films. Mesangial cell
TGF-b1 mRNA expression increased
significantly at six hours and continued to
increase until 48 hours in response to high
glucose. Compared to TGF-b1, the increase in
fibronectin mRNA in response to high glucose
was delayed, significant only at 24 and 48 hours.
Table 1. Effects of high glucose on mesangial cell TGF-b1 and
fibronectin mRNAs
Time after stimulaiton hours
0 3 6 12 24 48
TGF-b1 1.0 1.0 6 0.1 1.5 6 0.3a 1.5 6 0.1a 1.7 6 0.2a 1.8 6 0.4a
Fibronectin 1.0 1.0 6 0.1 1.2 6 0.1 1.2 6 0.2 1.4 6 0.2a 1.4 6 0.1a
Values are the intensity of densitometric readings of TGF-b1 and
fibronectin mRNAs corrected for GAPDH and relative to that of control
glucose at the given time point. Values are expressed as mean 6 SE of four
experiments.
a P , 0.05 compared to control glucose
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increased TGF-b1 secretion by mesangial cells when com-
pared to control glucose at 24 and 48 hours, with the
respective total TGF-b1 at 0.77 6 0.22 and 0.80 6 0.10
ng/ml in control glucose and 1.20 6 0.22 and 1.34 6 0.06
ng/ml in high glucose (P , 0.05). Conditioned media
without heat activation exhibited undetectable inhibition of
MLEC growth, suggesting that rat mesangial cells secreted
TGF-b1 protein mostly in inactive or latent forms.
Effects of high glucose and anti-TGF-b antibody on
fibronectin protein production by mesangial cells
To confirm the existence of fibronectin protein in condi-
tioned media, we performed immunoblot analysis. Cumu-
lative production of fibronectin by MC cultured in both
control and high glucose increased progressively with time
as summarized in Figure 3. Fibronectin was always detect-
able at six hours after the addition of serum-free control
glucose media and was assigned a relative value of 1.
Relative increase in fibronectin at 6, 12, 24 and 48 hours
was 1, 2.3 6 0.9, 3.1 6 0.2 and 4.7 6 0.3 under control
glucose, and 1.4 6 0.4, 2.6 6 0.8, 4.5 6 0.9 and 7.2 6 1.4
under high glucose, respectively. Thus, fibronectin protein
production in high glucose at 6, 12, 24, and 48 hours was
1.403, 1.133, 1.453, and 1.533 that of control glucose,
respectively. The difference between control and high
glucose was significant only at 48 hours (P , 0.05).
Studies with neutralizing antibody to TGF-b were per-
formed in order to examine the involvement of TGF-b on
increased fibronectin production by mesangial cells cul-
tured under high glucose conditions. Figure 4 demonstrates
that anti-TGF-b antibody at 25 mg/ml completely abolished
high glucose-induced fibronectin synthesis without a signif-
icant effect in basal production of fibronectin in control
glucose.
DISCUSSION
Increased glomerular TGF-b expression in experimental
diabetic animals [7–15] and diabetic patients [9, 16, 17],
attenuation of renal hypertrophy and enhanced ECM gene
expression in diabetic animals with anti-TGF-b antibody
[25], and inhibition of high glucose-induced mesangial cell
fibronectin and heparan sulfate proteoglycan synthesis by
TGF-b antisense oligonucleotides [24] suggest that TGF-b
is the final common mediator of diabetic nephropathy.
High glucose-induced collagen production by mesangial
cells [21] and fibronectin production by glomerular epithe-
lial cells [23] have been effectively inhibited by anti-TGF-b
antibody. However, the role of TGF-b1 in high glucose-
induced mesangial fibronectin production and the temporal
relations among high glucose, TGF-b1, and fibronectin in
mesangial cells have not been studied. The present study
examined effects of high glucose concentration on mesan-
gial cell TGF-b1 and fibronectin mRNA expression and
protein synthesis from 3 to 48 hours after stimulation.
Mesangial cells cultured under high glucose is an accepted
in vitro model of diabetic nephropathy and has been used to
investigate pathogenetic mechanisms of diabetic nephrop-
athy at molecular and cellular levels.
In agreement with previous studies [34, 35], there was
constitutive expression of TGF-b1 mRNA in quiescent
mesangial cells. In response to high glucose, TGF-b1
mRNA increased 1.5-fold above control at six hours and
1.8-fold at 48 hours. The extent of high glucose-induced
TGF-b1 mRNA expression was comparable to the findings
of Wolf et al [20], who reported a 50% increase at 48 hours
after stimulation, and Mogyorosi et al [22], who reported a
100% increase at 72 hours after stimulation. In contrast,
when synchronized mesangial cells were stimulated with
serum or phorbol ester, TGF-b1 mRNA began to increase
as early as one hour and reached the maximum at nine
hours to several-fold that of pre-stimulation values [34].
Mesangial cells used in the present study also exhibited a
fivefold increase in TGF-b1 mRNA in response to phorbol
ester (data not shown), comparable to the findings of
Kaname et al [34]. Angiotensin II caused a threefold
increase in mesangial TGF-b1 mRNA expression at four
hours, a sixfold at eight hours, and a threefold increase at
48 hours compared to control values [35].
Our study demonstrates that high glucose induces
TGF-b1 mRNA very early and significantly at six hours.
Wolf et al reported that high glucose increased TGF-b1
mRNA expression at 48 hours but not at 24 hours [20]. The
differences in mesangial cells used in the two studies,
primary rat mesangial cells in the present study versus
Fig. 2. Effects of high glucose on mesangial cell TGF-b1 bioactivity.
After incubation of quiescent mesangial cells with control (5.6 mM; M) or
high (30 mM; ) glucose for the given period, aliquots of mesangial cell
conditioned media were analyzed by a mink lung epithelial cell (MLEC)
growth inhibition assay. Values are expressed as mean 6 SE from three
separate experiments. *P , 0.05 compared to control glucose. Heat-
activated conditioned media showed time-dependent increase in TGF-b1
protein in both control and high glucose conditions. High glucose signif-
icantly increased TGF-b1 secretion at 24 and 48 hours when compared to
control glucose.
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transformed mouse mesangial cell line in the previous
study, and the presence versus absence of serum depriva-
tion period to synchronize the cell cycle before stimulation
may explain the apparent difference.
Compared to TGF-b1, the increase in fibronectin mRNA
expression in response to high glucose was delayed, that is,
it was significant only at 24 and 48 hours, which is consistent
with the view that high glucose-induced fibronectin synthe-
sis is mediated by TGF-b1. Ayo et al reported that high
glucose increased mRNAs of ECM including fibronectin at
three to seven days but not at one and two days [19]. In
their study, cells between the 20th and 40th passages were
used, and this may give a different time course in high
glucose-induced fibronectin mRNA expression [36]. The
significance of the present study is that high glucose
induced TGF-b1 mRNA expression prior to fibronectin in
the same cell. The rates of TGF-b1 and fibronectin mRNA
degradation following actinomycin D (5 mg/ml) were simi-
lar between mesangial cells cultured under control glucose
and under high glucose (data not shown), suggesting that
high glucose did not alter the stabilities of TGF-b1 and
fibronectin mRNAs in rat mesangial cells.
Elevation of TGF-b1 mRNA at six hours in response to
high glucose was followed by increased protein synthesis at
24 and 48 hours. Elevated fibronectin mRNA at 24 hours
was followed by a significant increase in fibronectin protein
at 48 hours. In addition, the amount of TGF-b protein
secreted by mesangial cells grown under control and high
glucose conditions during the first 24 hours were compara-
ble to the reported concentrations of TGF-b1 stimulating
synthesis of fibronectin [24] and collagen [21]. Further,
neutralizing antibody to TGF-b completely abolished the
Fig. 3. Immunoblot analysis of fibronectin
production by mesangial cell. After incubation
of quiescent mesangial cells with control (C; 5.6
mM; M) or high (H; 30 mM ) glucose for the
given period, aliquots of mesangial cell
conditioned media were electrophoresed under
reducing conditions and transferred onto
nitrocellulose membranes. Western blots were
performed as described in the text. Values are
expressed as mean 6 SE of three experiments.
*P , 0.05 compared to control glucose. The
inset Western blot is a representative of three
individual experiments. Shown here is
cumulative amount of fibronectin produced by
mesangial cells that progressively increased with
time in both control and high glucose. High
glucose induced significantly more fibronectin
synthesis than control glucose at 48 hours.
Table 2. Concentration of total protein in mesangial cell conditioned media
Time after stimulation hours
0 3 6 12 24 48
Control glucose mg/ml 36.0 6 6.6 31.1 6 7.9 30.5 6 7.5 35.1 6 7.4 33.9 6 7.9 32.5 6 8.5
High glucose mg/ml 26.0 6 5.0 27.6 6 4.2 32.2 6 4.2 30.9 6 5.4 36.0 6 2.1 36.1 6 3.6
Values are expressed as mean 6 SE of three separate experiments.
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high glucose-induced mesangial cell fibronectin production
without a significant change in basal production of fi-
bronectin in control glucose, indicating that high glucose-
induced but not basal production of fibronectin by mesan-
gial cells is due to an increase in TGF-b bioactivity. The
present data are thus consistent with the previous studies
[21, 23–25] demonstrating that increased ECM synthesis
associated with diabetes is mediated by TGF-b.
In conclusion, our data demonstrate that high glucose
induces TGF-b1 mRNA and protein synthesis very early
and prior to fibronectin production by mesangial cell.
TGF-b1 mRNA is induced as early as six hours after
stimulation with high glucose, while fibronectin mRNA is
induced at 24 hours. TGF-b1 protein synthesis was signif-
icantly increased at 24 hours and fibronectin protein at 48
hours. These findings along with complete inhibition by
anti-TGF-b antibody of high glucose-induced fibronectin
production support the view that high glucose-induced
fibronectin synthesis is mediated by TGF-b.
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Abbreviations used in this article are: DMEM, Dulbecco’s modified
eagle’s medium; ECM, extracellular matrix; EDTA, ethylenediamine
tetraacetic acid; FBS, fetal bovine serum; FN, fibronectin; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; HEPES, N-2-hydroxy-eth-
ylpiperazine-N9-2-ethane sulfonic acid; HG, high glucose; MC, mesangial
cell; MLEC, mink lung epithelial cell; MTT, 3-[4, 5-dimethyl-2-yl]-2,5-
diphenyl tetrazolium bromide; PBS, phosphate buffered saline; PCR,
polymerase chain reaction; SDS, sodium dodecyl sulfate; SSC, sodium
chloride and sodium citrate; TGF, transforming growth factor.
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